Proactive Management Strategies for Potential Gastrointestinal Adverse Reactions With Ceritinib in Patients With Advanced ALK-positive Non-Small-Cell Lung Cancer
Cancer Management and Research - New Zealand
doi 10.2147/cmar.s96471
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2016
Authors
Publisher
Informa UK Limited